XLV241206P129000
- 0.00
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
10 Health Care Stocks Whale Activity In Today's Session
Alector Downgraded to Underperform at BofA After Alzheimer's Trial Miss
Stock Of The Day: Where Will The Eli Lilly Rally End?
Insurance industry in emergency! CEO of UnitedHealth Insurance Company stabbed to death in New York, investor day event urgently canceled.
Brian Thompson, CEO of unitedhealth insurance company, was shot dead in Manhattan, New York. According to informed sources, the incident is believed to be a targeted attack. Unitedhealth insurance company, led by Thompson, is the largest private health insurance company in the usa, with revenue exceeding 281 billion dollars last year, accounting for more than two-thirds of unitedhealth group's total revenue. On Wednesday, after the early trading session, unitedhealth (UNH) saw its stock price rise over 2.9%, but then retraced most of its gains.
UnitedHealth Group Issued 2025 Guidance Ahead Of Now Stopped Investor Conference
Decoding Eli Lilly's Options Activity: What's the Big Picture?
Sector Update: Health Care Stocks Steady Pre-Bell Wednesday
Incyte Gains Amid Takeover Speculation
'UnitedHealthcare CEO Fatally Shot In Midtown: Sources' - PIX11
Eli Lilly and Co announced that Zepbound has better weight loss effects compared to novo-nordisk a/s Wegovy.
eli lilly and co announced on Wednesday that in a comparative trial, its weight-loss drug Zepbound had a greater weight-loss effect than the similar drug Wegovy from competitor novo-nordisk a/s; eli lilly and co is still evaluating the trial results, the company stated that it plans to publish them in a peer-reviewed journal and present them at medical conferences next year.
The results are even better than Wegovy! Eli Lilly and Co's weight loss drug Zepbound averaged a 20% weight loss over 72 weeks, jumping 2.5% in premarket.
Participants using novo-nordisk a/s's Wegovy only lost 14%. This result provides eli lilly and co an opportunity to catch up, especially with the obesity drug market expected to reach 130 billion dollars by the end of this decade.
U.S. Stock Outlook | Salesforce, Micron, and other technology stocks' earnings reports boost confidence! The three major futures indices are collectively rising in pre-market trading.
Okta surged 14% in the premarket! Q3 performance exceeded expectations, and AI applications continued to explode; Apple “stood by” Amazon and said it was considering pre-training large models using its AI chips.
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Powell Speech
Leading And Lagging Sectors For December 4, 2024
Jim Cramer: This Energy Stock Is A 'Winner,' But Navitas Semiconductor Is 'Losing A Lot Of Money'
Eli Lilly Announced Topline Results From The SURMOUNT-5 Phase 3b Open-label Randomized Clinical Trial
Trump's R&D policy ignites cash flow! These companies welcome a "financial spring"!
Trump's new policy on research and development may bring a "cash flow revolution" to usa companies! By allowing companies to record research and development expenses instantly, businesses can not only reduce their tax burden but also significantly enhance their liquidity.
UnitedHealth Group Introduces FY25 Guidance, Sees EPS $29.50-$30.00 Vs $29.92 Est.; Revenue $450B-$455B Vs $431.435B Est.
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
BeiGene Started at Overweight at Morgan Stanley on Brukinsa Market Share Growth